A further thought about the rising short position: This has been rising for months now. Is it really possible that the shorts know more than anybody else? How can negative info be hidden for this long from everybody else? Its possible, but just not plausible.
What effect does a rising short interest like this actually have on the financial health of the company? They don't need to raise money right now. And the pps isn't rising but it isn't going below 10 either. Are shorts hoping the next financial report next week can talked down so that it appears the company is doing poorly? Over 11 million shares short?
with a vengeance. Last year we skipped the tradition. But this year we're back to the usual game. The excuse was given with the arguments back and forth about how much HCV drug pricing will be affected by price cutting. Oh, last night with GILD - gosh 11 billion in sales isn't enough!!! Come on people, look at their balance sheet. How silly can you get?
Not sure; it feels like we're being jerked around,so I bought 500 more when Biocryst published on tw****er the latest flu report on CDC website. They are being very proactive.
" then not running Lynch 4 straight was incredibly stupid."
I still get that same horrible feeling remembering the missed Patrick Ewing finger roll which cost the Knicks the series against the Bulls in the 1990's. In that last play, there was plenty of time to make the dunk, but he got fancy. I suspect that Seattle, too, was trying to end the game in style.
I believe you are right that we are in a "show me financial performance" period. I looked at the analyst coverage listed on Fidelity's website over the weekend, and the majority of these talk mainly about cash flow, money ratios, the "quality" of their earnings, etc, as if this company is really in that stage. After all the good news in Dec and Jan, you would think BCRX would at least hold in the 11 to 12 range. I guess HAE isn't an important and publicized orphan disease.
"funny, i'm retired, and i look at what people do when they are retired"
I'm retired too from chemistry and programming for a WS firm: and I try to invest as best I can from what I learned along the way.
Growing pains is right. And today made me nuts. Seeing Biogen, on which I made out well buying and selling as it gyrated from 285 to 350. I swore I'd never sell it after I bought back at 320. And I sold again at 348. Today it goes to 390, and BCRX drops 4%. Did BIIB suck all the money from medium size biotechs?
I know propjoe. I've been at this a long time, and for every stock I once thought had major possibilities that turned bad, I can see where I ignored important warning information. But BRCX looks like it has everything going for it right now. I have held this for 7 yrs and the science looks great and management has been great. At least 2 WS firms agree! Merrill thinks not!
I sure would like to know what the short thesis is. It's unnerving that this has persisted for so long.
This stock is behaving very badly. Three catalysts in Jan. took pps from 10 to 12, and now we are back right where we started at about 10. Ugh!!!!
What's really pis&y is that the downgrade by McClean is duly recorded in Fidelity's scoresheet. BCRX's ratings are: 2 outperforms, 1 neutral, 2 underperforms, and 2 sells. Huh!